Phase I study in advanced cancer patients of a diversified prime-and-boost vaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses.

Marshall, J L; Hoyer, R J; Toomey, M A; Faraguna, K; Chang, P; Richmond, E; Pedicano, J E; Gehan, E; Peck, R A; Arlen, P; Tsang, K Y; Schlom, J

Marshall, J L; Hoyer, R J; Toomey, M A; Faraguna, K; Chang, P; Richmond, E; Pedicano, J E; Gehan, E; Peck, R A; Arlen, P; Tsang, K Y; Schlom, J.

Affiliation

Marshall JL; Georgetown University Medical Center, Vincent T. Lombardi Cancer Center, Washington, DC 20007, USA. marshallj@gunet.georgetown.edu

J Clin Oncol ; 18(23): 3964-73, 2000 Dec 01.

Article in En | MEDLINE | ID: mdl-11099326

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Vaccinia virus / Vaccines, Synthetic / Carcinoembryonic Antigen / Avipoxvirus / Cancer Vaccines / Neoplasms Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 2000 Document type: Article Affiliation country: Country of publication:

Search on Google

Add to My VHL

XML

PubMed Links